Home/Filings/4/0001144204-17-006949
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001144204-17-006949

CIK 0000810509operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 11:43 AM ET

Size

4.8 KB

Accession

0001144204-17-006949

Insider Transaction Report

Form 4
Period: 2017-02-06
Regan William J.
SVP of lobal Regulatory Strate
Transactions
  • Award

    NAVB Common Stock, $.001 par value

    2017-02-06$0.52/sh+79,155$41,161116,962 total
Footnotes (1)
  • [F1]Granted in lieu of cash bonus under 2015 and 2016 bonus plans.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 11:43 AM ET
Size
4.8 KB